Recent Updates — INLF

INLIF Limited closed a best-efforts registered direct offering on October 20, 2026, raising approximately $3.75 million in gross proceeds. The company issued 435,000 Class A ordinary shares alongside pre-funded warrants to purchase up to 1,908,750 additional shares. Each share or pre-funded warrant was sold with accompanying Series A, Series B, and Series C warrants at a combined price of $1.60 per unit. Maxim Group LLC acted as the sole placement agent for the transaction. INLIF intends to use the net proceeds for working capital, directors and officers insurance, and funding its Phase II manufacturing facility and R&D efforts. The company operates in the industrial automation sector, specializing in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms.

INLIF Limited terminated its At-The-Market (ATM) equity offering sales agreement with AC Sunshine Securities LLC, effective September 19, 2026. During the term of the agreement, the company sold approximately 981,261 Class A ordinary shares on a post-consolidation basis, generating $21.15 million in net proceeds and incurring $2.14 million in agent compensation costs. Following this transaction, the company has 1,046,390 Class A ordinary shares and 43,908 Class B ordinary shares issued and outstanding. INLIF Limited operates in the healthcare industry, specifically focusing on digital health solutions.

INLIF Limited filed its unaudited interim financial results for the six months ended June 30, 2026. The company reported total revenues of $12,942,657 and net income of $1,009,010, a significant turnaround from the $1,975,420 loss in the prior year period. Cash and cash equivalents increased to $45,465,962 from $6,717,787 at year-end 2025, driven by net proceeds of $32,344,244 from a PIPE offering and $21,150,492 from an ATM offering. The company also announced two share consolidations: a 1-for-16 consolidation effective April 6, 2026, followed by a 1-for-200 consolidation effective July 6, 2026. INLIF Limited operates in the industrial automation industry, producing and selling manipulator arms and accessories.

INLIF Limited shareholders approved several key resolutions at its Extraordinary General Meeting held on September 15, 2026. The company increased its authorized share capital from US$350,000 to US$2.72 billion, creating approximately 8.5 billion new Class A and B ordinary shares with a par value of US$0.32 each. Subsequently, the board was authorized to reduce the par value of all authorized shares from US$0.32 to US$0.0001. Shareholders also approved the migration of the company's incorporation from the Cayman Islands to the British Virgin Islands and adopted new governing documents to reflect these changes. Additionally, the firm ratified Enrome LLP as its independent auditor for the fiscal year ending December 31, 2026. INLIF Limited operates in the industrial automation sector, specializing in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms.